BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//London Global Cancer Week - ECPv6.18.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.lgcw.org.uk
X-WR-CALDESC:Events for London Global Cancer Week
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Etc/GMT
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20261104T153000
DTEND;TZID=Europe/London:20261104T183000
DTSTAMP:20261102T084307Z
CREATED:20260930T183326Z
LAST-MODIFIED:20261102T084307Z
UID:10000355-1793806200-1793817000@www.lgcw.org.uk
SUMMARY:Advancing Global Cancer Care: Generating Health Economic and Patient-Centred Evidence
DESCRIPTION:Register\nCollaborative research teams from the University of Herefordshire Hosted by Global Academic Foundation (Egypt) and St. Jude Children’s Research Hospital (USA) will host an event about “Advancing Global Cancer Care: Generating Health Economic and Patient-Centred Evidence”.  \nWe will present high-quality evidence about the cost-effectiveness of various treatment and diagnostic interventions for cancer care in low- and middle-income countries (LMICs) and globally\, and address important topics from the patients’ perspectives related to knowledge and attitudes about cancer risk factors and early diagnosis. We will cover the following research topics: \n1. Systematic Review on the Cost and Cost-Effectiveness of Treating Childhood Cancer in Low- and Middle-Income Countries \n2. Assessing the Costs and Cost-Effectiveness of Next-Generation Sequencing for Cancer Diagnoses: A Systematic Literature Review \n3. Cost-effectiveness of targeted therapies for advanced hepatocellular carcinoma in Low- and Middle-Income Countries: A systematic review            \n4. Breast Cancer Awareness\, Knowledge\, and Attitudes among Egyptian Women: A Literature Review \n5. Identifying Risk Factors for Adult Patients with Bladder Cancer in Egypt: A literature Review
URL:https://www.lgcw.org.uk/event/advancing-global-cancer-care-generating-health-economic-and-patient-centred-evidence/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2026/09/University-of-Hertfordshire-Hosted-by-Global-Academic-Foundation.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20261104T113000
DTEND;TZID=Europe/London:20261104T130000
DTSTAMP:20261102T084304Z
CREATED:20261015T175109Z
LAST-MODIFIED:20261102T084304Z
UID:10000374-1793791800-1793797200@www.lgcw.org.uk
SUMMARY:THE MISSING CHILDREN
DESCRIPTION:Registration link coming soon\nThe WHO Global Initiative for Childhood Cancer seeks to achieve at least 60% survival for children with cancer worldwide by 2030. However\, survival can only be improved for children who enter the health system and receive a diagnosis. Millions of children with cancer never reach an oncologist. Lost to delayed diagnosis\, misdiagnosis\, poverty\, and fragile health systems\, they remain invisible to care. This session is a global call to find the missing children—and ensure every child has a chance to be diagnosed\, treated\, and cured. By bringing together WHO leaders\, paediatricians\, health system experts\, survivors\, and policymakers\, the session will generate a global call to action to ensure that no child with cancer remains invisible.
URL:https://www.lgcw.org.uk/event/the-missing-children/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2023/05/SIOP-ISA-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20261102T150000
DTEND;TZID=Europe/London:20261102T163000
DTSTAMP:20261102T084246Z
CREATED:20260912T123835Z
LAST-MODIFIED:20261102T084246Z
UID:10000342-1793631600-1793637000@www.lgcw.org.uk
SUMMARY:Democratizing Oncology: Who Gets the Trial\, the Drug\, the Chance?
DESCRIPTION:Register\nDemocratizing Oncology: Who Gets the Trial\, the Drug\, the Chance? is a 90-minute virtual session hosted by OncoDaily that will bring together international leaders in oncology\, clinical research\, health policy\, and global cancer care to explore how access to cancer innovation can be made more equitable worldwide. Through three expert-led panel discussions\, the session will examine barriers to timely access to cancer medicines\, strategies to expand clinical trial participation\, and sustainable approaches to strengthening the global oncology workforce. The event will emphasize practical solutions\, cross-sector collaboration\, and scalable models that can improve cancer outcomes across both high-income and resource-limited settings.
URL:https://www.lgcw.org.uk/event/democratizing-oncology-who-gets-the-trial-the-drug-the-chance/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2026/09/Onco-Daily-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241114T170000
DTEND;TZID=Etc/GMT:20241114T180000
DTSTAMP:20250116T231124Z
CREATED:20241030T121111Z
LAST-MODIFIED:20250116T231124Z
UID:10000251-1731603600-1731607200@www.lgcw.org.uk
SUMMARY:Understanding the economic and regulatory challenges of cancer prevention to unlock future opportunities
DESCRIPTION:Register\nAn estimated 22 million people worldwide will have cancer in 2030. Policy goals of reducing cancer mortality often default to a discourse of advancing therapeutic strategies\, strongly supported by the pharmaceutical industry. However\, the impact of cancer therapeutics on survival remains limited. \nA cancer diagnosis and its treatment\, successful or not\, impose a heavy burden on patients and their loved ones. Preventing cancers from arising would reduce mortality and the negative social and psychological impact of this disease. \nCurrent estimates suggest that at least 30-50% of cancers are preventable with opportunities to go further by better understanding the underlying mechanisms of cancer genesis and risk. In this shared Cancer Research UK and Consilium Scientific webinar\, experts in broad aspects of health policy and economics will discuss the historical funding limitations of cancer prevention research compared to therapeutics. \nWhat are the current regulatory and economic barriers to advancing cancer prevention? Do we need novel models of health economics to promote cancer prevention? What are the challenges of behavioural and interventional prevention strategies? How can they be overcome? \nJoin us at this webinar focused on highlighting the growing global importance of cancer prevention and the vast opportunities ahead.
URL:https://www.lgcw.org.uk/event/understanding-the-economic-and-regulatory-challenges-of-cancer-prevention-to-unlock-future-opportunities/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://www.lgcw.org.uk/wp-content/uploads/2024/10/Understanding-economic-regulatory-challenges-of-cancer-prevention-to-unlock-future-opportunities-1.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241114T170000
DTEND;TZID=Etc/GMT:20241114T180000
DTSTAMP:20250116T232029Z
CREATED:20240819T191931Z
LAST-MODIFIED:20250116T232029Z
UID:10000237-1731603600-1731607200@www.lgcw.org.uk
SUMMARY:Cancer control in the face of climate change
DESCRIPTION:Register\nAchieving effective cancer control internationally will be increasingly challenged by climate change and environmental damage. Efforts to improve cancer prevention\, detection\, and care\, are already impacted by extreme weather events and rising pollution. Any efforts to mitigate these effects will need to include steps by health care systems to reduce their carbon footprint\, since health care accounts for roughly 4-5% of all carbon emissions globally. These challenges are greatest in countries with less well developed health systems. In this session we will bring together experts to discuss the ways in which cancer policy and health systems can adapt to and mitigate the impact of climate change. \nhttps://docs.google.com/document/d/1Hg19J4TNlC6FxEp5PK_rXu6_5ngbylbDFOY1BSwMiVg/edit?usp=sharing
URL:https://www.lgcw.org.uk/event/cancer-control-in-the-face-of-climate-change/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2023/05/ouch-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241114T130000
DTEND;TZID=Etc/GMT:20241114T140000
DTSTAMP:20241113T235629Z
CREATED:20241011T175751Z
LAST-MODIFIED:20241113T235629Z
UID:10000244-1731589200-1731592800@www.lgcw.org.uk
SUMMARY:Addressing antimicrobial resistance (AMR) for better cancer care - the importance of effective antimicrobial stewardship
DESCRIPTION:Register\nPeople with cancer are more susceptible to infections due to the lowering of their immune defences. As many as one in five cancer patients undergoing treatment is hospitalized due to an infection and infections are the second leading cause of death for people living with cancer.  The emergence of drug-resistant pathogens is a grave threat to cancer care.  There is an urgent need to address the critical issue of AMR as it will roll back progress made to date in modern medicines\, including cancer treatment. The time to act is now. \nIn this regard\, the second UN high-level meeting on AMR took place on 26 September 2024\, where the political declaration on addressing AMR was adopted by Members States. At this meeting\, Member States committed to a set of actions to mitigate AMR across all sectors\, using a One Health approach that recognises the interconnectedness between human\, animal\, agriculture and environmental health. There are several commitments outlined under action on human health to effectively address AMR including focus on knowledge and awareness raising\, ensuring access to appropriate therapies\, effective stewardship and infection prevention and control (IPC) etc. Progress in these areas will have a positive impact on cancer care outcomes.  \nAll key stakeholders must come together to accelerate progress and implement actions to address AMR at national\, regional and global levels.  AMR is a complex and widespread issue that requires immediate and collaborative action.  \nIn this regard\, the London Global Cancer Week is an annual event that brings together all the relevant stakeholders and experts in the field. It is an ideal platform to bring together experts from the cancer and AMR fields to discuss what action needs to be taken to address this challenge.  \nObjective and expected results \nThe objective of this virtual dialogue is to emphasize the crucial role of effective antimicrobial stewardship (AMS) in promoting the responsible use of medications to manage infections\, ultimately contributing to improved outcomes in cancer care.
URL:https://www.lgcw.org.uk/event/addressing-antimicrobial-resistance-amr-for-better-cancer-care-the-importance-of-effective-antimicrobial-stewardship/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/10/uicc-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241114T130000
DTEND;TZID=Etc/GMT:20241114T140000
DTSTAMP:20241113T235629Z
CREATED:20240829T172848Z
LAST-MODIFIED:20241113T235629Z
UID:10000241-1731589200-1731592800@www.lgcw.org.uk
SUMMARY:Cancer Surgery: Who should do it? Global Perspectives
DESCRIPTION:Register\nEnsuring the delivery of timely\, safe\, and affordable surgical cancer care is dependent on the presence of an adequately trained and competent surgical cancer workforce. It is well-known that there is a major shortage of surgeons that are capable of delivering surgical cancer care on the global stage. In addition to the shortage\, there is also extreme variability in the training paradigms and practice patterns leading to inconsistency in the capabilities of the surgeon and thereby the care that is provided.  \nThis session will include speakers who will focus on the type of surgical workforce required to deliver high-quality cancer surgery\, pertaining to their region of the world.
URL:https://www.lgcw.org.uk/event/cancer-surgery-who-should-do-it-global-perspectives/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2023/07/gfcs-logo-2023.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241114T120000
DTEND;TZID=Etc/GMT:20241114T130000
DTSTAMP:20241113T235629Z
CREATED:20241018T174707Z
LAST-MODIFIED:20241113T235629Z
UID:10000248-1731585600-1731589200@www.lgcw.org.uk
SUMMARY:Quality Metrics in Cancer Surgery: Regional Perspectives
DESCRIPTION:Register\nEnsuring the delivery of safe\, timely\, high-quality\, and affordable cancer surgical care in the Global South requires an adequate number of well-trained surgeons.  \nBuilding sustainable\, contextually appropriate\, and resource-stratified educational and research platforms is essential for creating this workforce and delivering high-quality cancer care.  \nThis session will bring together experts to discuss the current situation\, highlight challenges\, and propose strategies for improvement.
URL:https://www.lgcw.org.uk/event/quality-metrics-in-cancer-surgery-regional-perspectives/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2023/08/IASO-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241114T100000
DTEND;TZID=Etc/GMT:20241114T113000
DTSTAMP:20241113T235629Z
CREATED:20240708T230553Z
LAST-MODIFIED:20241113T235629Z
UID:10000215-1731578400-1731583800@www.lgcw.org.uk
SUMMARY:Investing in Cancer Prevention and Control in Low-and Middle-Income Countries including Small Island Developing States: A Strategic Multi-Country Dialogue.
DESCRIPTION:Register\nThe Commonwealth\, which represents over 30 per cent of the world’s population\, carries a substantial share of the global cancer incidence and mortality burden. Cancer rates in the Commonwealth have risen by 35% over the past decade\, with a further 35% increase in incidence of cancer predicted in the years leading up to 2030 and a 39% increase in cancer mortality. \nFor specific cancers like cervical cancer\, the burden is even higher. The Commonwealth carries 40 percent share of the global cervical cancer incidence burden\, and 43 percent of the global mortality burden. A report from the Daffodil Centre\, a world-leading research centre on cervical cancer control and policy revealed that co-ordinated efforts to meet the WHO 90-70-90 cervical cancer targets in Commonwealth Low-and Middle-Income countries (LMICs) have the potential to avert almost 40 million cases and save over 35 million lives within a century – alleviating more than half of the burden that these countries would otherwise bear.  \nThere is therefore a need for strengthened coordinated and collective action to accelerate Cancer control in the Commonwealth. It is for this reason that the Commonwealth Secretariat is organising a strategic multi-country dialogue on Cancer prevention and control centred around increasing investment on cancer control with a focus on LMICs including Small Island Developing States (SIDS).  \nThe Objectives are: \n   -To raise awareness of the current burden of Cancers in the Commonwealth and  \n    understand key challenges and roadblocks preventing Cancer prevention and control. \n  -To share national\, regional\, and Commonwealth-wide case studies and strategies to  \n    advance Cancer prevention and control efforts. \n  -To build a compelling case for increased investment for Cancer prevention and control in  \n    the Commonwealth. \n  – To share the Report of the Lancet Oncology Commission on Cancer in the  \n    Commonwealth. \nThis event which will take place during the commemoration of the London Global Cancer week (LGCW) will bring together all the 56 Commonwealth member countries to share experiences\, challenges\, and best practices partnerships for Cancer Control investments.  \nPartners and Stakeholders championing cancer control in the world will also have the opportunity during the event to share some multi-dimensional approaches and opportunities for investment in cancer which countries can tap into.  \nThe event will equally provide a platform for young people and people with lived experiences of Cervical cancer to share their views and call for action on investment in Cancer control in the Commonwealth. This event will be open to the general public for maximum participation.
URL:https://www.lgcw.org.uk/event/investing-in-cancer-prevention-and-control-in-low-and-middle-income-countries-including-small-island-developing-states-a-strategic-multi-country-dialogue/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/common-wealth-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T160000
DTEND;TZID=Etc/GMT:20241113T173000
DTSTAMP:20250120T212229Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250120T212229Z
UID:10000212-1731513600-1731519000@www.lgcw.org.uk
SUMMARY:Women\, Power\, and Cancer - NCI Session at LGCW 2024
DESCRIPTION:Register\nThe Lancet Commission on Women\, Power\, and Cancer addresses urgent questions at the intersection of social inequality\, cancer risk and outcomes\, and the status of women in society. A year out from the publication of the 2023 Commission report\, the NCI convenes this London Global Cancer Week session to review progress made and discuss plans for evaluation\, patient engagement\, and opportunities for further research.
URL:https://www.lgcw.org.uk/event/a-framework-for-monitoring-progress-at-the-intersection-of-women-power-and-cancer/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/NCI-event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T160000
DTEND;TZID=Etc/GMT:20241113T170000
DTSTAMP:20241230T205652Z
CREATED:20240823T182243Z
LAST-MODIFIED:20241230T205652Z
UID:10000238-1731513600-1731517200@www.lgcw.org.uk
SUMMARY:Global Disparities in Supportive Care in Cancer\, one size does not fit all
DESCRIPTION:Register\nEducational Objectives: \n-Understand the differing definitions and issues related to healthcare disparities across regions of the world. \n-Analyse the different perspectives from global stakeholders regarding the most important issues related with cancer supportive care. \n-Apply the knowledge obtained form the webinar to better understand the way in which to evaluate the local disparities in supportive care in cancer and the possibilities to interact with other stakeholders to tackle these disparities.
URL:https://www.lgcw.org.uk/event/global-disparities-in-supportive-care-in-cancer-one-size-does-not-fit-all/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/MASCC-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T160000
DTEND;TZID=Etc/GMT:20241113T170000
DTSTAMP:20241231T005840Z
CREATED:20240708T230552Z
LAST-MODIFIED:20241231T005840Z
UID:10000213-1731513600-1731517200@www.lgcw.org.uk
SUMMARY:Every facility\, every country: SIOP Global Mapping of Paediatric Oncology Services
DESCRIPTION:Register\nThe SIOP Global Mapping Programme of Paediatric Oncology Services has the potential to benefit everyone\, especially the children\, adolescents\, and young adults for whom we care. Mapping allows us to know where care is being delivered\, by whom and with which resources. \nWe will present the current landscape of paediatric oncology services around the world and the benefits and challenges of mapping. Join us to learn about the power of mapping for professionals\, patients and families\, governments\, non-governmental organizations\, and other key stakeholders.
URL:https://www.lgcw.org.uk/event/every-facility-every-country-siop-global-mapping-of-paediatric-oncology-services/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/SIOP-global-mapping.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T153000
DTEND;TZID=Etc/GMT:20241113T170000
DTSTAMP:20241112T234348Z
CREATED:20241004T081029Z
LAST-MODIFIED:20241112T234348Z
UID:10000243-1731511800-1731517200@www.lgcw.org.uk
SUMMARY:Impact of climate change in cancer care: experiences around the globe.
DESCRIPTION:Register\nThe webinar aims to increase awareness of the impact of climate change on patients and healthcare professionals;  and highlight ways in which the climate impacts of healthcare can be reduced\, and the role of clinical trials in this endeavour.  This involves discussion of the importance of climate change in cancer care\, testimonies from oncologists of the challenges for patients and providers in climate change impacted areas\, and solution focused talks on sustainability integration into patient care and clinical research. \nRunning Order: \n1. Welcome (Eduardo L. Cazap\, SLACOM) \n2.Introduction about climate change (Joan Schiller\, OUCH-I) \n3. Impact on patients and providers – \na. Experience from Brazil (Gustavo Gossling\, LACOG) \nb. Experience from Nigeria ( Olubukola Ayodele\, University Hospitals of Leicester NHS Trust\, UK ) \nc. Experience from The Philippines (Dr Roselle De Guzman\, Manila Central University-FDT Medical Foundation Hospital) \n4. Tool kits \na. Clinical trials (Lisa Fox\, The Institute of Cancer Research) \nb. Medical Oncology (Seamus O’Reilly\, Cancer Trials Ireland) \nc. Radiotherapy\, (Katie Lichter\, (University of California\, San Francisco\, USA)) \nd. Surgery\, (Shelley Hwang\, Duke University)
URL:https://www.lgcw.org.uk/event/impact-of-climate-change-in-cancer-care-experiences-around-the-globe-2/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/10/Logos-together-LGCW-Claire-Hopkins.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T150000
DTEND;TZID=Etc/GMT:20241113T160000
DTSTAMP:20241112T234348Z
CREATED:20240807T202815Z
LAST-MODIFIED:20241112T234348Z
UID:10000232-1731510000-1731513600@www.lgcw.org.uk
SUMMARY:Introducing Cardio-Oncology: A Vital Addition for the Cancer Journey
DESCRIPTION:Register\nWith the increasing efficacy of cancer therapies concerns for quality of life continue to grow. Cardiovascular health is recognized as one of the most important areas for patients with cancer and survivors to pay attention to. This session will provide an overview of this developing field including some global perspectives.
URL:https://www.lgcw.org.uk/event/introducing-cardio-oncology-a-vital-addition-for-the-cancer-journey/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/08/international-Cardio-Oncology-Society.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T143000
DTEND;TZID=Etc/GMT:20241113T153000
DTSTAMP:20250116T232912Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250116T232912Z
UID:10000211-1731508200-1731511800@www.lgcw.org.uk
SUMMARY:Achieving population-based palliative care: Learnings from Telangana\, India
DESCRIPTION:Register\nJoin Drs. Gayatri Palat and Gillian Fyles\, Mr. Swarup Immaraju\, and Ms. Vineela Rapelli as they discuss the road to achieving population-based palliative care in Telangana. \nAccess to effective and affordable palliative and end-of-life care for those with life-limiting diseases\, including cancer\, in lesser–resourced countries is limited\, resulting in a high burden of distress due to pain\, symptoms\, stigma\, isolation\, and financial compromise. \nThis presentation will address how Telangana\, a state in southern India\, moved from an absence of palliative care in the early 2000’s to a current\, internationally recognized palliative care program serving 38 million people in 33 administrative districts. The steps involved in creating this capacity and the key factors underlying successful implementation\, will be presented\, along with a roadmap for implementation that can be replicated elsewhere. We will describe how a collaboration between a state government and Indian and Canadian NGOs resulted in palliative care now being accessible to all\, including in the poorest and the remotest areas of the state.
URL:https://www.lgcw.org.uk/event/achieving-population-based-palliative-care-learnings-from-telangana-india/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://www.lgcw.org.uk/wp-content/uploads/2022/05/two-worlds-banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T120000
DTEND;TZID=Etc/GMT:20241113T130000
DTSTAMP:20241027T123607Z
CREATED:20241021T201403Z
LAST-MODIFIED:20241027T123607Z
UID:10000249-1731499200-1731502800@www.lgcw.org.uk
SUMMARY:“Opportunities in Latin America for improving precision medicine in oncology”
DESCRIPTION:Register \nContext and Rationale \nCancer treatment has seen remarkable progress in recent years\, largely due to the advancements in precision medicine. This innovative approach enables personalized treatments that are tailored to the genetic and molecular characteristics of each patient’s tumor\, revolutionizing the way cancer is treated. With the help of precision diagnostics and genetic testing\, oncologists can now identify specific mutations that drive cancer growth\, paving the way for targeted therapies that are not only more effective but also less toxic than traditional treatments. These breakthroughs have led to significantly improved patient outcomes\, particularly in Europe and the United States\, where health systems have invested heavily in integrating these technologies into standard oncology care. \nIn regions like Europe and the U.S.\, organizations such as ASCO (American Society of Clinical Oncology) and ESMO (European Society for Medical Oncology) have been at the forefront of research and clinical application of precision oncology. Experts in these organizations have helped shape the development and implementation of cutting-edge therapies\, as well as frameworks for precision diagnostics that have set a global benchmark. Their work has provided the foundation for clinical guidelines that support the integration of genetic profiling and biomarker-driven treatments in cancer care. These developments have not only enhanced treatment efficacy but also reduced the economic and physical burden of ineffective therapies. \nHowever\, while these advancements have become more commonplace in Europe and the U.S.\, Latin America faces significant challenges in replicating this progress. There are substantial gaps in infrastructure\, technology\, and funding across the region\, which hinder the adoption of precision medicine. Many countries lack the capacity for widespread genetic testing and molecular diagnostics\, and access to targeted therapies is often limited to a few specialized centers\, creating disparities in care. Additionally\, regulatory frameworks and reimbursement models are not yet fully equipped to support these innovations\, making it difficult for patients to benefit from the full spectrum of precision oncology. \nThis meeting aims to bring together the leading Cancer Institutes of Latin America\, along with key stakeholders and global experts\, to assess the current state of precision medicine in the region. The goal is to diagnose the situational challenges and explore the opportunities for improving cancer care through precision oncology. By drawing on the expertise of professionals involved in ASCO and ESMO\, the meeting will also serve as a platform to share international best practices\, promote collaboration\, and create actionable strategies for overcoming the region’s barriers to innovation. \nMeeting Objectives \n1. Assess the current state of precision medicine and diagnostics in the region: \nReview progress in using molecular diagnostics\, genetic testing\, and the implementation of targeted therapies across different cancer types in Latin America. Identify barriers to accessing these technologies. \n2. Share best practices in genetic testing and targeted therapies: \nFacilitate the exchange of successful experiences in using genetic testing to identify key mutations and selecting appropriate targeted therapies for each patient. \n3. Foster collaboration between cancer institutions: \nExplore cooperation among Cancer Institutes and other organizations to create networks that improve diagnostic capabilities\, share genetic data\, and enhance access to precision therapies. \n4. Develop regional strategies to improve access to precision medicine: \nDiscuss public policies\, funding\, and regulatory frameworks that will help increase the availability of genetic testing and access to targeted therapies \n5. Proposed Agenda Topics \n1. Overview of precision diagnostics and genetic testing in Latin America: \nThe current state of access to advanced molecular diagnostics\, genetic sequencing\, and laboratory capacities across the region. \n2. Advances in targeted therapies (target therapies): \nLatest innovations in the use of targeted therapies and how genetic tests help identify key biomarkers to personalize cancer treatment. \n3. Challenges and barriers to implementing genetic testing and access to precision therapies: \nIdentification of financial\, technological\, and regulatory obstacles that limit the use of genetic testing in clinical practice and access to targeted treatments. \n4. Collaboration and regional networks to enhance access to precision medicine: \nExploration of collaborative models between countries to improve early diagnosis\, data sharing\, and equitable access to targeted therapies. \n5. Public policy to promote precision medicine in oncology: \nProposals for policies that encourage investment in advanced diagnostic technologies and facilitate access to innovative treatments through subsidies\, insurance coverage\, and price regulation. \nExpected Outcomes \n• A current analysis of the state of precision medicine\, genetic testing\, and access to targeted therapies in Latin America. \n• Identification of the main barriers countries face in implementing precision diagnostics and using targeted therapies. \n• Proposals for inter-institutional collaboration to optimize the use of molecular diagnostic technologies and improve accessibility to personalized treatments. \n• Strategic recommendations to improve public policies that promote precision medicine in the region.
URL:https://www.lgcw.org.uk/event/opportunities-in-latin-america-for-improving-precision-medicine-in-oncology/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/10/selac-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T120000
DTEND;TZID=Etc/GMT:20241113T130000
DTSTAMP:20250116T234104Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250116T234104Z
UID:10000209-1731499200-1731502800@www.lgcw.org.uk
SUMMARY:Opportunities to prevent liver cancer via urgent acceleration of viral hepatitis elimination
DESCRIPTION:Register\nWith almost a million new cases per year worldwide\, liver cancer is the sixth most common cancer globally\, with the highest rates of new cases and deaths seen in Asia and Africa. With the number of people diagnosed with or dying from liver cancer predicted to rise by 55% by 2040\, liver cancer will place an increasingly heavy burden on health systems across the world. \nThe two major hepatitis viruses—hepatitis B virus and hepatitis C virus—are oncogenic\, and viral hepatitis is a major cause of liver cancer. Despite the availability of an effective vaccine for hepatitis B and a cure for hepatitis C\, efforts to test and treat individuals for viral hepatitis and to prevent these infections are suboptimal. Ramping up these efforts is a critical component of cancer prevention that must be integrated and implemented into cancer prevention efforts globally. \nThe session provides the audience with the opportunity to learn more about the link between viral hepatitis and liver cancer\, and the key challenges facing efforts to eliminate viral hepatitis. The session will also focus on actionable aspects of hepatitis elimination with the end goal of preventing liver cancer.
URL:https://www.lgcw.org.uk/event/preventing-liver-cancer-through-eliminating-viral-hepatitis/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/Logos-for-LGCW.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T110000
DTEND;TZID=Etc/GMT:20241113T120000
DTSTAMP:20241112T234347Z
CREATED:20241017T074508Z
LAST-MODIFIED:20241112T234347Z
UID:10000246-1731495600-1731499200@www.lgcw.org.uk
SUMMARY:Cancer Control through Tobacco Control in East Africa
DESCRIPTION:Register\nIn 2023\, Cancer Research UK and the Union for International Cancer Control launched a joint flagship programme in Kenya and Uganda with the aim of reducing the incidence of preventable cancers through effective tobacco control policies. Join us for this webinar during London Global Cancer Week\, hosted by Cancer Research UK\, to hear directly from Cancer Organisations working to build broad-based Tobacco Tax Coalitions who will be sharing their experiences\, challenges and opportunities in advocating for tobacco control\, and the importance of partnerships and coalition-building in these efforts\, as well as lessons from similar efforts supported by CRUK in in Sri Lanka and Nepal.  \nSpeakers: \nAlex Wright – Head of Global Policy & Programmes\, CRUK \nYannick Romero – Senior Knowledge & Advocacy Manager\, UICC \nPanellists: \nRachel Devotsu – McCabe Centre for Law and Cancer \nPhoebe Ongadi – Kenya Network of Cancer Organisation \nDennis Olodi – Uganda Cancer Society \nOlivia Stevens – KIVU International
URL:https://www.lgcw.org.uk/event/cancer-control-through-tobacco-control-in-east-africa/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/11/CRUK-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T093000
DTEND;TZID=Etc/GMT:20241113T110000
DTSTAMP:20241112T234347Z
CREATED:20240708T230552Z
LAST-MODIFIED:20241112T234347Z
UID:10000208-1731490200-1731495600@www.lgcw.org.uk
SUMMARY:Data on ALL\, Hodgkins and Wilms from Partner countries - improvement over time.
DESCRIPTION:Register\nThe Global Child Cancer subgroup of the Children’s Cancer and Leukaemia Group is made up of paediatric oncology doctors\, nurses and allied health professionals. Several paediatric oncology units have links with partner units in developing countries which have been present for many years. At this years London Cancer week we will present survival data on three key tumour types Leukaemia\, Hodgkins disease and Wilms tumour treatment highlighting the improvements that have happened over time. We will then discuss how data collection can be improved and what are the barriers to data collection.
URL:https://www.lgcw.org.uk/event/data-on-all-hodgkins-and-wilms-from-partner-countries-improvement-over-time/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/CCLG-Logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241113T090000
DTEND;TZID=Etc/GMT:20241113T100000
DTSTAMP:20241109T105455Z
CREATED:20240729T210107Z
LAST-MODIFIED:20241109T105455Z
UID:10000229-1731488400-1731492000@www.lgcw.org.uk
SUMMARY:Oral cancer - causes\, early detection and prevention
DESCRIPTION:Register\nThis upcoming London Global Cancer Week (LGCW) C3 will be joined by Professor Warnakulasuriya – emeritus professor of Oral Medicine and Experimental Pathology at King’s College London – to discuss oral cancer\, it’s causes\, detection and prevention. \nAbout the speaker: \nProfessor Warnakulasuriya is an emeritus professor of Oral Medicine and Experimental Pathology at King’s College London\, UK and was the Chairman of the Oral Medicine Division at King’s College Hospital and at Guy’s Hospital\, London from 2005 -2015. He has made major contributions in cancer epidemiology\, oral medicine and experimental pathology. He is the Director of the WHO Collaborating Centre for Oral Cancer. Professor Warnakulasuriya received the IADR Distinguished Scientist Award in Oral Medicine and Pathology in 2014\, IADR Distinguished Scientist Award in Global Oral Health in 2022. He was elected a Fellow of King’s College London (FKC) for sustained and significant contributions to the College. He holds the Honorary Life Membership of the BSOM and International Association for Oral Pathologists. \nWhy oral cancer: \nOral cancer is the 13th most common cancer worldwide. Despite\, oral cancer being so prevalent and untreated dental caries (tooth decay) being the most common health condition according to the Global Burden of Disease 2019\, oral health is still often overlooked. Oral cancer is largely preventable and shares risk factors with other NCDs\, with tobacco and alcohol among the leading causes. C3 has long recognised the importance of tackling oral diseases including oral cancer through prevention and early detection as part of our mission to address NCDs. In fact\, since 2022 C3 have been working alongside Colgate\, the Commonwealth Nurses and Midwives Federation (CNMF)\, and the World Continuing Education Alliance (WCEA) as part of Colgate Bright Smiles\, Bright Futures\, to raise awareness about the importance of oral health for nurses and midwives and elevate the need for oral health education in practice. Learn more about C3’s oral health programmes.
URL:https://www.lgcw.org.uk/event/the-link-between-oral-health-and-cancer/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/C3-Collaborating.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241112T200000
DTEND;TZID=Etc/GMT:20241112T220000
DTSTAMP:20241111T234057Z
CREATED:20240729T210105Z
LAST-MODIFIED:20241111T234057Z
UID:10000228-1731441600-1731448800@www.lgcw.org.uk
SUMMARY:Oncology Nursing Now; Where do we stand globally?
DESCRIPTION:Register\nThe Global Power of Oncology Nursing Group (GPON) presents our 2024 annual webinar. Our mission is to provide a global forum for the recognition of the specialty of oncology nursing\, to bridge the gap of disparities in cancer care and share oncology nurses’ experiences\, challenges\, and successes over the past year\, as part of London Global Cancer Week (LGCW). The second virtual session of our 2024 programme is for the West (Americas and Caribbean and early risers in Oceania) and runs from 20.00UTC to 22.30UTC (Mexico City 14:00/Rio de Janeiro 17:00/Sydney 07:00-Wednesday) with simultaneous translation in Spanish. This year we feature speakers and discussants from around the region. Many sub-themes were suggested by GPON members:  \n• Economic Investment in (Oncology) Nursing: a short video from the International Council of Nursing  \n• Empathy/Mindfulness and Self Care in Oncology Nursing: Canadian oncology nurse speaking about an innovative program to address oncology nursing self-care in their hospital  \n• Oncology Nursing Care in Humanitarian Crises: oncology nurse speaker from Palestine \n• Oncology Nurse Research Highlight: an oncology nurse from Peru speaking about quality of life and nursing care of the elderly with cancer in her large cancer hospital in Lima. \n• Inspirational Speaker: a speaker with the lived experience of having had cancer \nIn 2023\, we had 31 speakers and videos from 23 countries and 350 participants from 46 countries. The overwhelming number of nurses caring for patients with cancer are in low- and middle-income countries. As the largest single healthcare workforce\, nurses stand ready to do their share towards care for all and cure for more. GPON highlights and supports the work of all nurses working across the cancer continuum everywhere.
URL:https://www.lgcw.org.uk/event/oncology-nursing-now-where-do-we-stand-globally-2/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/GPON.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241112T140000
DTEND;TZID=Etc/GMT:20241112T150000
DTSTAMP:20250119T175807Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250119T175807Z
UID:10000207-1731420000-1731423600@www.lgcw.org.uk
SUMMARY:From Policy to Practice: Transforming Cancer Care in Africa by Implementing Guideline-Concordant Care
DESCRIPTION:Register\nThe panel discussion will explore the critical steps necessary to implement guideline concordant care\, in order to improve cancer outcomes in Africa. There are contextual barriers to delivering quality cancer treatment\, including limited resources\, insufficient healthcare infrastructure\, and disparities in access to care. This session will bring together leading experts\, policymakers\, and cancer care providers to discuss strategies for translating national cancer control plans (NCCP) into guideline-concordant care that aligns with international quality of care standards. \nKey topics will include the development and dissemination of NCCPs tailored to the African context\, innovative approaches to training healthcare professionals and embedding a culture of quality improvement in care delivery. Furthermore\, the session will explore the integration of culturally-tailored\, palliative care and symptom management along the entire cancer care continuum. Finally\, this session will highlight successful case studies from specific African countries where policy changes have led to tangible improvements in clinical practice and patient outcomes. \nParticipants will gain insights into effective collaboration between ministries of health\, non-governmental organizations\, and the private sector. Additionally\, the discussion will address the importance of community engagement and patient advocacy in driving systemic change. By the end of the session\, attendees will have a clearer understanding of the practical steps needed to translate NCCPs into practice\, ultimately aiming to reduce cancer mortality rates in Africa through guideline-concordant care delivery.
URL:https://www.lgcw.org.uk/event/from-policy-to-practice-transforming-cancer-care-in-africa-by-implementing-guideline-concordant-care/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/University-of-Pennsylvania.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241112T133000
DTEND;TZID=Etc/GMT:20241112T150000
DTSTAMP:20241111T234056Z
CREATED:20240729T210103Z
LAST-MODIFIED:20241111T234056Z
UID:10000227-1731418200-1731423600@www.lgcw.org.uk
SUMMARY:The Lancet Oncology Commission on Radiotherapy and Theranostics
DESCRIPTION:Register\nFollowing on from The Lancet Oncology Commission on Expanding Global Access to Radiotherapy\, The Lancet Oncology Commission on Radiotherapy and Theranostics aims to assess the current status of access and availability of radiotherapy and address the important issue of access to the promising field of theranostics at a global level. A marked disparity in the availability of radiotherapy machines between high-income and low-income and middle-income countries (LMICs) was previously identified and remains a major problem. Access and availability of radiopharmaceuticals is impacting on theranostics use in many high-income countries and LMICs. The availability of a suitably trained and credentialled workforce has also been highlighted as a major limiting factor in effective implementation of radiotherapy\, and theranostics\, particularly in LMICs. \nIn this Lancet Webinar\, authors of The Lancet Oncology Commission will discuss action points and investment that could enhance access to radiotherapy and theranostics\, particularly in LMICs\, to realise health and economic benefits and reduce the global burden of cancer by increasing access to these essential treatments
URL:https://www.lgcw.org.uk/event/the-lancet-oncology-commission-on-radiotherapy-and-theranostics/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/lancet-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241112T130000
DTEND;TZID=Etc/GMT:20241112T140000
DTSTAMP:20241111T234056Z
CREATED:20240708T230552Z
LAST-MODIFIED:20241111T234056Z
UID:10000204-1731416400-1731420000@www.lgcw.org.uk
SUMMARY:Defining opportunities to improve survival and quality of life for women in low- and middle-income countries through the Every Woman Study.  Could the findings of an ovarian cancer patient experience study benefit the wider community?
DESCRIPTION:Register\nWith data gathered from almost 2\,500 women with ovarian cancer from 22 low- and middle-income countries\, join us for an overview of the study and results\, country leads\, and commentary from three global oncology leaders committed to transformational change. The event will be a mix of presentation\, videos and live discussion.
URL:https://www.lgcw.org.uk/event/defining-opportunities-to-improve-survival-and-quality-of-life-for-women-in-low-and-middle-income-countries-through-the-every-woman-study-could-the-findings-of-an-ovarian-cancer-patient-experience-3/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2024/07/ovariancancer.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241112T120000
DTEND;TZID=Etc/GMT:20241112T130000
DTSTAMP:20250126T165438Z
CREATED:20240807T202814Z
LAST-MODIFIED:20250126T165438Z
UID:10000231-1731412800-1731416400@www.lgcw.org.uk
SUMMARY:World-wide trends in patterns of care for breast\, cervical and ovarian cancers – The VENUSCANCER project
DESCRIPTION:Watch here\nThe CONCORD programme documented wide global differences in survival trends\, still persistent in 2010-2014\, for women diagnosed with breast cancer (66% in India; over 90% in the US and Australia)\, cervical (52% in Ecuador; 77% in Korea) or ovarian (16% in India; 57% in Costa Rica) cancers. \nThe VENUSCANCER project\, embedded in the CONCORD programme\, examines whether global differences in survival are attributable to differences in disease biology between populations\, or patterns of care\, or socio-economic status. \nCancer registries were invited to submit data for a single year of complete incidence during 2015-2018\, for which availability and completeness of high-resolution variables (e.g.\, stage\, staging procedures\, biomarkers\, treatment) were highest. VENUSCANCER offered financial support to 11 registries in low- and middle-income countries to enable collection of these data.  \nDuring this webinar we will discuss the world-wide adherence to international clinical guidelines for cervical and ovarian cancer.
URL:https://www.lgcw.org.uk/event/world-wide-trends-in-patterns-of-care-for-breast-cervical-and-ovarian-cancers-the-venuscancer-project/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2023/05/erc-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241112T070000
DTEND;TZID=Etc/GMT:20241112T110000
DTSTAMP:20241111T234056Z
CREATED:20240726T073741Z
LAST-MODIFIED:20241111T234056Z
UID:10000226-1731394800-1731409200@www.lgcw.org.uk
SUMMARY:Oncology Nursing Now; Where do we stand globally?
DESCRIPTION:Register\nThe Global Power of Oncology Nursing Group (GPON) presents our 2024 annual webinar. Our mission is to provide a global forum for the recognition of the specialty of oncology nursing\, to bridge the gap of disparities in cancer care and share oncology nurses’ experiences\, challenges\, and successes over the past year\, as part of London Global Cancer Week (LGCW).  \nOur programme for 2024 runs in two sessions – Tuesday 12th November early morning UK time is Part 1) 07.00 UTC – 11.00 UTC for the Eastern hemisphere (i.e. Europe\, Africa and east to Oceania)\, followed by the West session\, late evening UK time.  \nThis year we plan to feature the following subthemes featuring speakers and discussants from around the world including resource-constrained settings.  Many of these subthemes were suggested by GPON members: \n•Economic Investment in (Oncology) Nursing  \n•Empathy/Mindfulness and Self Care in Oncology Nursing \n•Oncology Nursing Care in Humanitarian Crises \n•Oncology Nurse Research Highlight \n•Inspirational Speaker: An African this year\, now living in the UK with  Lived Experience of Cancer  \nIn 2023\, we had 31 speakers and videos from 23 countries and a total of 350 participants from 46 countries. This year\, we want to go even further. \nThe conferences (East and West in the evening) showcase the contributions and expertise of oncology nurses in tackling the burden of cancer across the continuum from screening to end-of-life care or survivorship through engaging stories\, discussion\, and presentations by colleagues from around the world. Most oncology nurse presenters are from LMICs. As the largest single healthcare workforce\, nurses stand ready to do their share towards a care/cure for all\, and GPON highlights and supports their ongoing work in this direction.
URL:https://www.lgcw.org.uk/event/oncology-nursing-now-where-do-we-stand-globally/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/GPON.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241111T150000
DTEND;TZID=Etc/GMT:20241111T163000
DTSTAMP:20250119T180958Z
CREATED:20240812T203215Z
LAST-MODIFIED:20250119T180958Z
UID:10000233-1731337200-1731342600@www.lgcw.org.uk
SUMMARY:Prioritizing cancer screening and early diagnosis in the EMR
DESCRIPTION:Register\nThe majority of cancer patients in the Eastern Mediterranean Region (EMR) are diagnosed in the late stages\, which increases treatment costs and resources\, and compromises health outcomes and survival rates. Directing healthcare spending towards screening should be an immediate policy priority because it will help support early diagnosis\, thereby lowering treatment costs\, while reducing the cancer mortality rate.
URL:https://www.lgcw.org.uk/event/prioritizing-cancer-screening-and-early-diagnosis-in-the-emr/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://www.lgcw.org.uk/wp-content/uploads/2022/08/EMNCDA-Logo-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241111T140000
DTEND;TZID=Etc/GMT:20241111T153000
DTSTAMP:20250815T213916Z
CREATED:20241018T174636Z
LAST-MODIFIED:20250815T213916Z
UID:10000247-1731333600-1731339000@www.lgcw.org.uk
SUMMARY:Cancer and Conflict in Africa:  a spotlight on the Sahel
DESCRIPTION:Register\nThe Sahel region in Africa stretches from Senegal and Gambia on the Atlantic coast through Mali\, Mauritania\, Burkina Faso\, Nigeria\, Niger\, Chad\, and Sudan to the northwestern part of Ethiopia and Eritrea on the Red Sea coast. Many of the 16 African countries in conflict are contiguous\, stretching from the western Sahel through the Horn of Africa\, encompassing the Lake Chad Basin and Great Lakes regions.    \nClimate change\, conflict and political instability have resulted in the biggest humanitarian crises in the world\, severely disrupting healthcare. The cancer care needs of conflict- affected populations continues to be a low priority in international and continental responses to the crises in the Sahel.  In this session we will be shining a light on cancer care in the Sahel\, hearing from those practising in these countries and other stakeholders about what the future holds for the Region.
URL:https://www.lgcw.org.uk/event/cancer-and-conflict-in-africa-a-spotlight-on-the-sahel/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2022/06/Aortic-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241111T140000
DTEND;TZID=Etc/GMT:20241111T150000
DTSTAMP:20250116T233905Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250116T233905Z
UID:10000202-1731333600-1731337200@www.lgcw.org.uk
SUMMARY:Progress in childhood cancer data sharing to inform policy and accelerate care and research
DESCRIPTION:Register\nImproving outcomes for children and young people with cancer requires extensive multi-faceted knowledge of clinical factors\, tumour biology\, therapeutic approaches and the health care system in which these are delivered. New approaches to data integration/linkage and analysis are now possible\, to accelerate understanding of these rare and heterogeneous cancers and the factors that influence survival and morbidity. \nThis session aims to showcase recent initiatives to harness the power of collecting and comparing data at a large scale. Examples will be given of the importance of standardised data for international comparisons and analysis of future trends. Ways to achieve more equitable\, locally-informed cancer intelligence for national cancer control planning will be discussed. The ambition is to achieve global reach and show how data can support implementation of the WHO Global Initiative for Childhood Cancer.
URL:https://www.lgcw.org.uk/event/progress-in-childhood-cancer-data-sharing-to-inform-policy-and-accelerate-care-and-research/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2021/05/siop-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Etc/GMT:20241111T130000
DTEND;TZID=Etc/GMT:20241111T140000
DTSTAMP:20250116T233445Z
CREATED:20240708T230552Z
LAST-MODIFIED:20250116T233445Z
UID:10000203-1731330000-1731333600@www.lgcw.org.uk
SUMMARY:Bridging medicine and emotional support in cancer therapy
DESCRIPTION:Register\nThe Children’s Cancer Center of Lebanon\, in collaboration with the wellness instructors\, CCCL team members\, survivors\, partners\, and national NGOs\, will host a groundbreaking virtual dialog discussing the importance of the cancer patient’s wellbeing and mental health. The session intends to allow the attendees to learn more about the benefits of having a comprehensive treatment that combines the medical and the mental well-being of cancer patients. The session will provide the speakers a platform to discuss their work\, experiences and most importantly feelings and emotions. They will be sharing happy and sometimes sad stories they encountered\, testimonials\, and benefits of a fully integrated therapy of care for patients everywhere. \nThis session will permit panelists and attendees to share their personal stories\, highlighting the physical\, emotional\, and social challenges\, and to provide valuable insights into the holistic needs of every cancer patient. It will promote and emphasize the importance of expressing emotions and feelings\, especially during treatment\, and highlight the significance of building partnerships that support patients and their families. The session aims to foster dialogue among panelists with unique approaches to the psychosocial aspects of patient care and call on national NGOs to integrate psychosocial activities into their support and care for cancer patients.
URL:https://www.lgcw.org.uk/event/bridging-medicine-and-emotional-support-in-cancer-therapy/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://www.lgcw.org.uk/wp-content/uploads/2023/05/CCCL.png
END:VEVENT
END:VCALENDAR